ETERNA THERAPEUTICS INC (ERNA)
US1140822099 - Common Stock
ETERNA THERAPEUTICS INC
NASDAQ:ERNA (1/6/2025, 2:47:53 PM)
0.3265
-0.01 (-3.97%)
Company Profile
Eterna Therapeutics, Inc. engages in the provision of cell engineering therapies. The company is headquartered in Cambridge, Massachusetts and currently employs 8 full-time employees. The firm has in-licensed a portfolio of over 100 patents covering key mRNA cell engineering technologies, including technologies for mRNA cell reprogramming, mRNA gene editing, the NoveSlice and UltraSlice gene-editing proteins, and the ToRNAdo mRNA delivery system (collectively mRNA technology platform). Its mRNA gene-editing technology is designed to delete, insert and repair deoxyribonucleic acid (DNA) sequences in living cells, which may be useful for correcting disease-causing mutations, making cells resistant to infection and degenerative disease, modulating the expression of immunoregulatory proteins to enable the generation of durable allogeneic cell therapies, and engineering immune cells to more effectively fight cancer.
Company Info
ETERNA THERAPEUTICS INC
1035 Cambridge Street, Suite 18A
Cambridge MASSACHUSETTS
P: 12125821199
Employees: 8
Website: https://eternatx.com/
ERNA News
7 days ago - ChartmillCurious about the stocks that are showing activity after the closing bell on Monday?Curious about the stocks that are showing activity after the closing bell on Monday?
10 days ago - ChartmillTop movers in Friday's after hours sessionAs the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
a month ago - Eterna TherapeuticsEterna Therapeutics Announces Up to $1 Million Stock Repurchase ProgramEterna Therapeutics Announces $1 Million Stock Repurchase Program...
2 months ago - Eterna TherapeuticsEterna Therapeutics Regains Compliance with NASDAQ for Continued ListingEterna Therapeutics Regains Compliance with NASDAQ for Continued Listing ...
2 months ago - Eterna TherapeuticsEterna Therapeutics Completes Strategic Financial Restructuring with the Aim to Accelerate its Developmental Activities and Long-Term SuccessEterna Therapeutics Completes Strategic Financial Restructuring with the Aim to Accelerate its Developmental Activities and Long-Term Success...
3 months ago - Eterna TherapeuticsEterna Therapeutics and Factor Bioscience Announce Exclusive License and Collaboration Agreement to Accelerate Cell Therapy Development for Oncology, Autoimmune, and Rare DiseasesCAMBRIDGE, Mass., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”) and Factor Bioscience Limited...
ERNA Twits
Here you can normally see the latest stock twits on ERNA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
